- SNP v genu ABCB1: vliv na expresi a klinickopatologickou charakteristiku pacientek s karcinomem prsu2008 | 1. lékařská fakulta
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Farmaceutická fakulta v Hradci Králové
- Epidural Analgesia With Sufentanil in Relation to OPRM1 and ABCB1 Polymorphisms2019 | 1. lékařská fakulta
- OPRM1 and ABCB1 Polymorphisms and Their Effect on Postoperative Pain Relief With Piritramide2015 | 1. lékařská fakulta
- Development of high-resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma2019 | 2. lékařská fakulta, Lékařská fakulta v Plzni, 3. lékařská fakulta
- Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients2008 | 2. lékařská fakulta
- Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro2015 | Farmaceutická fakulta v Hradci Králové
- Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices2021 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis2012 | 2. lékařská fakulta
- Farmakogenetika dabigatranu a sekundární prevence ischemické cévní mozkové příhody2022 | 2. lékařská fakulta
- Analgesic effects of piritramide in acute postoperative pain - comparison of intramuscular administration with patient-controlled intravenous analgesia and impact of OPRM1 and ABCB1 polymorphisms2022 | 1. lékařská fakulta
- Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro2018 | Farmaceutická fakulta v Hradci Králové
- ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines2023 | Lékařská fakulta v Plzni, 3. lékařská fakulta, Přírodovědecká fakulta
- Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)2013 | Farmaceutická fakulta v Hradci Králové
- Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics2019 | Farmaceutická fakulta v Hradci Králové
- Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine2016 | Farmaceutická fakulta v Hradci Králové
- Maternal and Neonatal Effects of Remifentanil in Women Undergoing Cesarean Section in Relation to ABCB1 and OPRM1 Polymorphisms2015 | 1. lékařská fakulta
- Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro2013 | Farmaceutická fakulta v Hradci Králové
- Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients2017 | 1. lékařská fakulta
- Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats2018 | Farmaceutická fakulta v Hradci Králové
- Contribution of ABCB1 and CYP2D6 Genotypes to the Outcome of Tamoxifen Adjuvant Treatment in Premenopausal Women With Breast Cancer2015 | 1. lékařská fakulta
- Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1(-/-) lethal mouse model of neonatal hyperbilirubinemia2017 | 1. lékařská fakulta
- Entrectinib reverses cytostatic resistance through the inhibition of ABCB1 efflux transporter, but not the CYP3A4 drug-metabolizing enzyme2020 | Farmaceutická fakulta v Hradci Králové
- Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta2014 | Farmaceutická fakulta v Hradci Králové
- Sonidegib potentiates the cancer cells' sensitivity to cytostatic agents by functional inhibition of ABCB1 and ABCG2 in vitro and ex vivo2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme2020 | Farmaceutická fakulta v Hradci Králové
- Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)2016 | Farmaceutická fakulta v Hradci Králové
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro2015 | Farmaceutická fakulta v Hradci Králové
- Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter2022 | Farmaceutická fakulta v Hradci Králové
- Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové